pharma · refractory hypotension in distributive shock
PAION Pharma
PAION Pharma GmbH
PAION Pharma is a pharma organization headquartered in EU. Primary therapeutic focus areas include refractory hypotension in distributive shock. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent
Aachen, DE HQ
2024 Founded
30 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Aachen, DE
- Founded
- 2024
- Employees
- 30
- Programs
- 1
- Drugs
- 6
- Patents
- 0
CRH07
Phase 3 · small molecule · refractory hypotension in distributive shock
CRH07 for refractory hypotension in distributive shock is a Phase 3 program (small_molecule) at PAION Pharma GmbH with 1 ClinicalTrials.gov record(s).
Internal code CRH07
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- PAION Pharma GmbH
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- refractory hypotension in distributive shock
- Status
- active
- Trials
- 1